Toronto, Canada

Atul Verma

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 8.7

ph-index = 2

Forward Citations = 31(Granted Patents)


Location History:

  • Ontario, CA (2020)
  • Toronto, CA (2019 - 2023)

Company Filing History:


Years Active: 2019-2023

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Atul Verma: Innovator in Electrocardiogram Technology

Introduction

Atul Verma is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of electrocardiogram (ECG) technology, holding a total of four patents. His work focuses on improving the detection of focal sources in cardiac signals, which has important implications for medical diagnostics.

Latest Patents

One of Atul Verma's latest patents is titled "Region of interest focal source detection using comparisons of R-S wave magnitudes and LATs of RS complexes." This innovative system and method aim to identify focal sources by detecting ECG signals over time. The method involves creating an R-S map that comprises an R-to-S ratio for each ECG signal, identifying local activation times (LATs), and correlating these elements to pinpoint focal sources effectively.

Career Highlights

Throughout his career, Atul Verma has worked with prominent companies in the medical technology sector. He has been associated with Biosense Webster Ltd. in Israel and Biosense Webster, Inc. in the United States. His experience in these organizations has allowed him to develop and refine his innovative approaches to ECG technology.

Collaborations

Atul has collaborated with talented individuals in his field, including Yaniv Ben Zrihem and Ziyad Zeidan. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Atul Verma's contributions to ECG technology demonstrate his commitment to innovation in the medical field. His patents reflect a deep understanding of cardiac signals and their implications for patient care. His work continues to influence the landscape of medical diagnostics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…